Acute Inhibition of Drp1 Mitigates Adverse Cardiac Remodelling following Chronic Reperfused Myocardial Infarction

被引：0
|
作者：
Donner, Daniel G. [1 ,2 ,3 ]
Kong, Anne M. [4 ]
Lees, Jarmon G. [4 ,5 ]
Kiriazis, Helen [1 ,3 ]
Brown, Aascha [1 ]
Tham, Yow K. [1 ,2 ,3 ,6 ]
Holien, Jessica K. [7 ]
Shen, Hsin-Hui [8 ,9 ]
Hausenloy, Derek J. [10 ,11 ,12 ,13 ]
Lim, Shiang Y. [4 ,5 ,12 ,14 ]
机构：
[1] Baker Heart & Diabet Inst, Melbourne, Vic 3004, Australia
[2] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia
[3] Univ Melbourne, Baker Dept Cardiometab Hlth, Melbourne, Vic 3010, Australia
[4] St Vincents Inst Med Res, OBrien Inst Dept, 42 Fitzroy St, Fitzroy, Vic 3065, Australia
[5] Univ Melbourne, Dept Med & Surg, Melbourne, Vic, Australia
[6] La Trobe Univ, Dept Cardiovasc Res Translat & Implementat, Melbourne, Vic 3086, Australia
[7] RMIT Univ, STEM Coll Engn & Hlth, Sch Sci, Melbourne, Vic, Australia
[8] Monash Univ, Dept Mat Sci & Engn, Faulty Engn, Clayton, Vic 3800, Australia
[9] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, VIC 3800, Australia
[10] UCL, Hatter Cardiovasc Inst, Inst Cardiovasc Sci, 67 Chenies Mews, London WC1E 6HX, England
[11] Duke NUS Med Sch, Cardiovasc & Metab Disorder Programme, 8 Coll Rd, Singapore 169857, Singapore
[12] Natl Heart Ctr, Natl Heart Res Inst Singapore, 5 Hosp Dr, Singapore 169609, Singapore
[13] Natl Univ Singapore, Yong Loo Lin Sch Med, 1E Kent Ridge Rd, Singapore 119228, Singapore
[14] Monash Univ, Fac Pharm & Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2024年
基金：
英国医学研究理事会;
关键词：
D O I：
10.1007/s10557-024-07633-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Myocardial Haemorrhage Following Reperfused Acute Myocardial Infarction is a Predictor of Adverse Left Ventricular Remodelling and Late Ventricular Arrhythmia
    Mather, Adam N.
    Fairbairn, Timothy A.
    Artis, Nigel
    Greenwood, John P.
    Plein, Sven
    CIRCULATION, 2010, 122 (21)
  • [2] Comprehensive cardiac magnetic resonance imaging predicts adverse remodelling following acute myocardial infarction
    Scott, Anne E.
    Semple, Scott I. K.
    Redpath, Thomas W.
    Hillis, Graham S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A163 - A163
  • [3] microRNA-21 inhibition as a treatment for preventing adverse cardiac remodelling and dysfunction following myocardial infarction
    Fernandez, I. Duran
    Ramanujam, D.
    Beck, C.
    Vaccarello, P.
    Engelhardt, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S6 - S6
  • [4] RUNX1 DEFICIENCY PROTECTS AGAINST ADVERSE CARDIAC REMODELLING FOLLOWING MYOCARDIAL INFARCTION
    McCarroll, C. S.
    He, W.
    Foote, K. K.
    Nather, K.
    Fattah, C.
    Elliott, E. B. A.
    Cochrane, A.
    Bowman, P.
    Bell, M.
    Kubin, T.
    Braun, T.
    Nicklin, S. A.
    Cameron, E. R.
    Loughrey, C. M.
    HEART, 2015, 101 : A3 - A3
  • [5] Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction
    Tripathi, Himi
    Al-Darraji, Ahmed
    Abo-Aly, Mohamed
    Peng, Hsuan
    Shokri, Elica
    Chelvarajan, Lakshman
    Donahue, Renee R.
    Levitan, Bryana M.
    Gao, Erhe
    Hernandez, Gabriela
    Morris, Andrew J.
    Smyth, Susan S.
    Abdel-Latif, Ahmed
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 149 : 95 - 114
  • [6] DPP-4 INHIBITION ATTENUATES CARDIAC DYSFUNCTION AND ADVERSE REMODELLING FOLLOWING MYOCARDIAL INFARCTION IN EXPERIMENTAL DIABETES
    Connelly, K. A.
    Desjardins, J.
    Advani, A.
    Kabir, G.
    Zhang, Y.
    Advani, S. L.
    Yuen, D. A.
    Thai, K.
    Gilbert, R. E.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S328 - S328
  • [7] STING inhibition in myocardial remodelling following myocardial infarction
    Rech, L.
    Abdellatif, M.
    Poettler, M.
    Stangl, V.
    Ulcar, E.
    Ablasser, A.
    Rainer, P. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3242 - 3242
  • [8] Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
    Berezin, Alexander E.
    Berezin, Alexander A.
    DISEASE MARKERS, 2020, 2020
  • [9] Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
    Abbate, Antonio
    Van Tassell, Benjamin W.
    Seropian, Ignacio M.
    Toldo, Stefano
    Robati, Roshanak
    Varma, Amit
    Salloum, Fadi N.
    Smithson, Lisa
    Dinarello, Charles A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (04) : 319 - 322
  • [10] Biological markers and cardiac remodelling following the myocardial infarction
    Gruzdeva, Olga
    Dyleva, Yulia
    Uchasova, Evgenya
    Akbasheva, Olga
    Karetnikova, Victoria
    Kashtalap, Vasiliy
    Shilov, Aleksandr
    Polikutina, Olga
    Slepynina, Yulia
    Barbarash, Olga
    AGING-US, 2019, 11 (11): : 3523 - 3535
12345